IonQ, Inc.

(New York Stock Exchange)
Back to all articles
Slightly Bullish +15

Analysts See Near-Doubling Upside For IonQ (NYSE: IONQ) Even As Technical Breakdown Deepens Before November Earnings

Acquisition Analyst upgrade Government funding AI-generated analysis

πŸ“ˆ Analysts project an average price target of $65.77 for IonQ, implying roughly 100% upside from its current trading level of approximately $32.95.

πŸ“‰ Technical indicators show deterioration with the stock closing below both 50-day and 200-day moving averages, forming a bearish crossover signaling sustained selling pressure.

πŸ’° IonQ received $7.5 million in follow-on funding from the Air Force Research Laboratory to advance quantum networking capabilities including free-space optical links.

🀝 The company opened a new quantum innovation center in partnership with the University of Cambridge on October 15 to expand research efforts.

πŸ›‘οΈ IonQ announced plans to acquire cybersecurity firm Elisity on October 12 to extend its strategic reach into security applications.

πŸ“‰ Third-quarter consensus loss estimates widened from 22 cents to 30 cents per share over the past month due to macro headwinds.

πŸ“ˆ Despite wider losses, IonQ expects a dramatic 91.6% year-over-year EPS improvement compared to the $3.58 loss recorded in the year-ago quarter.

⏳ Upcoming earnings on November 5 are expected to provide clarity on management's forward guidance and resolve current market tension.

πŸ“Š The stock has declined 26.1% over the past month, mirroring a broader sell-off in the quantum computing sector alongside peers like Rigetti Computing.

Bullish Signals
  • Analysts project an average price target of $65.77, implying roughly 100% upside from the current trading level of approximately $32.95.
  • IonQ secured $7.5 million in follow-on funding from the Air Force Research Laboratory to advance quantum networking capabilities and hardware.
  • The company opened a new quantum innovation center in partnership with the University of Cambridge to expand its research footprint.
  • IonQ announced plans to acquire cybersecurity firm Elisity to extend its strategic reach into security applications.
  • Projected third-quarter loss per share represents a dramatic 91.6% year-over-year improvement compared to the $3.58 loss in the prior quarter.
Risk Factors
  • The stock closed below both its 50-day and 200-day moving averages, forming a bearish crossover that signals sustained selling pressure.
  • IonQ's stock declined 26.1% over the past month as part of a broader sell-off in the quantum computing sector.
  • Higher interest rates and elevated inflation are eroding valuations for growth-stage companies like IonQ, making the investment case harder to sustain.
  • Third-quarter consensus loss estimates have widened from 22 cents to 30 cents per share over the past month due to macro headwinds.
Full Analysis
Analysts project a near-doubling of upside for IonQ (NYSE: IONQ), with an average price target of $65.77 representing roughly 100% potential gain from its current trading level of approximately $32.95. This bullish consensus contrasts sharply with deteriorating technical indicators, as the stock closed below both its 50-day and 200-day moving averages on October 28, forming a bearish crossover that signals sustained selling pressure. Despite the technical weakness, IonQ's operational progress offers nuance to the market picture. The company recently secured $7.5 million in follow-on funding from the Air Force Research Laboratory for quantum networking capabilities and opened a new quantum innovation center in partnership with the University of Cambridge. Additionally, IonQ announced plans to acquire cybersecurity firm Elisity to extend its strategic reach into security applications. Macro headwinds persist as higher interest rates erode valuations for growth-stage companies like IonQ, which burns cash on future earnings potential. Consequently, third-quarter consensus loss estimates have widened from 22 cents to 30 cents per share over the past month, though this still represents a dramatic 91.6% year-over-year improvement compared to the prior quarter's $3.58 loss. With earnings scheduled for November 5, investors are awaiting management's forward guidance to resolve the tension between analyst optimism and technical weakness. The Zacks Rank of 3 suggests a Hold rating, indicating that waiting for the upcoming report may be prudent before committing to a fresh position in either direction.